The role of apoptosis in oral disease: Mechanisms; aberrations in neoplastic, autoimmune, infectious, hematologic, and developmental diseases; And therapeutic opportunities

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 97, Issue 4, 2004, Pages 476-490

  Nikitakis, Nikolaos G ^a,c   Sauk, John J ^a   Papanicolaou, Stavros I ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE; CISPLATIN; FLUOROURACIL; PROTEIN BCL 2; PROTEIN P53;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CARCINOGENESIS; CELL DEATH; DEGENERATIVE DISEASE; GENE THERAPY; HEMATOLOGIC DISEASE; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MOUTH CANCER; MOUTH DISEASE; NECROSIS; SIDE EFFECT; SJOEGREN SYNDROME; SQUAMOUS CELL CARCINOMA; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS INFECTION;

EID: 1942452833     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2003.12.032     Document Type: Article

References (155)

1. Clarke P.G., Clarke S. Nineteenth century research on naturally occurring cell death and related phenomena. Anat Embryol (Berl). 193:1996;81-99.
2. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 26:1972;239-257.
3. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
4. Hetts S.W. To die or not to die: an overview of apoptosis and its role in disease. JAMA. 279:1998;300-307.
5. Fraser A., Evan G. A license to kill. Cell. 85:1996;781-784.
6. Vaux D.L., Strasser A. The molecular biology of apoptosis. Proc Natl Acad Sci U S A. 93:1996;2239-2244.
7. Majno G., Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol. 146:1995;3-15.
8. Saunders M.W., Birchall M.A. Apoptosis, matters of life and death. J Laryngol Otol. 112:1998;822-826.
9. Ellis H.M., Horvitz H.R. Genetic control of programmed cell death in the nematode C. elegans. Cell. 44:1986;817-829.
10. Ellis R.E., Yuan J.Y., Horvitz H.R. Mechanisms and functions of cell death. Annu Rev Cell Biol. 7:1991;663-698.
11. Vaux D.L., Haecker G., Strasser A. An evolutionary perspective on apoptosis. Cell. 76:1994;777-779.
12. Green D.R. Apoptotic pathways: paper wraps stone blunts scissors. Cell. 102:2000;1-4.
13. Hengartner M.O. The biochemistry of apoptosis. Nature. 407:2000;770-776.
14. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science. 281:1998;1312-1316.
15. Nicholson D.W. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 6:1999;1028-1042.
16. Green D.R., Reed J.C. Mitochondria and apoptosis. Science. 281:1998;1309-1312.
17. Marchetti P., Castedo M., Susin S.A., Decaudin D., Hirsch T., Zamzami N., et al. Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med. 184:1996;1155-1160.
18. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489.
19. Zou H., Li Y., Liu X., Wang X. An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem. 274:1999;11549-11556.
20. Wallach D., Boldin M., Varfolomeev E., Beyaert R., Vandenabeele P., Fiers W. Cell death induction by receptors of the TNF family: towards a molecular understanding. FEBS Lett. 410:1997;96-106.
21. Baker S.J., Reddy E.P. Modulation of life and death by the TNF receptor superfamily. Oncogene. 17:1998;3261-3270.
22. Rossi D., Gaidano G. Messengers of cell death: apoptotic signaling in health and disease. Haematologica. 88:2003;212-218.
23. Chinnaiyan A.M., O'Rourke K., Tewari M., Dixit V.M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 81:1995;505-512.
24. Nagata S., Golstein P. The Fas death factor. Science. 267:1995;1449-1456.
25. Green D.R. Apoptotic pathways: the roads to ruin. Cell. 94:1998;695-698.
26. Pegoraro L., Palumbo A., Erikson J., et al. A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia. Proc Natl Acad Sci U S A. 81:1984;7166-7170.
27. Reed J.C., Cuddy M., Slabiak T., Croce C.M., Nowell P.C. Oncogenic potential of bcl-2 demonstrated by gene transfer. Nature. 336:1988;259-261.
28. Hengartner M.O., Horvitz H.R. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell. 7:1994;665-676.
29. Reed J.C. Double identity for proteins of the Bcl-2 family. Nature. 387:1997;773-776.
30. Adams J.M., Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 281:1998;1322-1326.
31. Yang J., Liu X., Bhalla K., et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275:1997;1129-1132.
32. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1997;1132-1136.
33. Lane D.P. Cancer. p53, guardian of the genome. Nature. 358:1992;15-16.
34. Sionov R.V., Haupt Y. The cellular response to p53: the decision between life and death. Oncogene. 18:1999;6145-6157.
35. Thomas A., Giesler T., White E. p53 mediates bcl-2 phosphorylation and apoptosis via activation of the Cdc42/JNK1 pathway. Oncogene. 19:2000;5259-5269.
36. Lohrum M.A., Vousden K.H. Regulation and activation of p53 and its family members. Cell Death Differ. 6:1999;1162-1168.
37. Barr P.J., Tomei L.D. Apoptosis and its role in human disease. Biotechnology (N Y). 12:1994;487-493.
38. Campisi J. Cellular senescence and apoptosis: how cellular responses might influence aging phenotypes. Exp Gerontol. 38:2003;5-11.
39. Higami Y., Shimokawa I. Apoptosis in the aging process. Cell Tissue Res. 301:2000;125-132.
40. Zornig M., Hueber A., Baum W., Evan G. Apoptosis regulators and their role in tumorigenesis. Biochim Biophys Acta. 1551:2001;F1-F37.
41. Kaufmann S.H., Gores G.J. Apoptosis in cancer: cause and cure. Bioessays. 22:2000;1007-1017.
42. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331.
43. Strasser A., Huang D.C., Vaux D.L. The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumourigenesis and resistance to chemotherapy. Biochim Biophys Acta. 1333:1997;F151-F178.
44. Polverini P.J., Nor J.E. Apoptosis and predisposition to oral cancer. Crit Rev Oral Biol Med. 10:1999;139-152.
45. Strasser A., Harris A.W., Bath M.L., Cory S. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature. 348:1990;331-333.
46. Gastman B.R. Apoptosis and its clinical impact. Head Neck. 23:2001;409-425.
47. Kamer A.R., Krebs L., Hoghooghi S.A., Liebow C. Proliferative and apoptotic responses in cancers with special reference to oral cancer. Crit Rev Oral Biol Med. 10:1999;58-78.
48. Loro L.L., Vintermyr O.K., Johannessen A.C. Cell death regulation in oral squamous cell carcinoma: methodological considerations and clinical significance. J Oral Pathol Med. 32:2003;125-138.
49. Schoelch M.L., Le Q.T., Silverman S. Jr., et al. Apoptosis-associated proteins and the development of oral squamous cell carcinoma. Oral Oncol. 35:1999;77-85.
50. Singh B.B., Chandler F.W. Jr., Whitaker S.B., Forbes-Nelson A.E. Immunohistochemical evaluation of bcl-2 oncoprotein in oral dysplasia and carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 85:1998;692-698.
51. Xie X., Clausen O.P., De Angelis P., Boysen M. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue. Cancer. 86:1999;913-920.
52. Nylander K., Dabelsteen E., Hall P.A. The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. J Oral Pathol Med. 29:2000;413-425.
53. Chen Q., Samaranayake L.P., Zhen X., Luo G., Nie M., Li B. Up-regulation of Fas ligand and down-regulation of Fas expression in oral carcinogenesis. Oral Oncol. 35:1999;548-553.
54. Ravindranath N.M., Nishimoto K., Chu K., Shuler C. Cell-surface expression of complement restriction factors and sialyl Lewis antigens in oral carcinoma: relevance to chemo-immunotherapy. Anticancer Res. 20:2000;21-26.
55. Fishelson Z., Donin N., Zell S., Schultz S., Kirschfink M. Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors. Mol Immunol. 40:2003;109-123.
56. Gandarillas A., Goldsmith L.A., Gschmeissner S., Leigh I.M., Watt F.M. Evidence that apoptosis and terminal differentiation of epidermal keratinocytes are distinct processes. Exp Dermatol. 8:1999;71-79.
57. Yin H.F., Okada N., Takagi M. Apoptosis and apoptotic-related factors in mucoepidermoid carcinoma of the oral minor salivary glands. Pathol Int. 50:2000;603-609.
58. Fujita S., Shibata Y., Takahashi H., Tsuda N. Apoptosis-induced and -suppressed cells in salivary gland adenoid cystic carcinoma: correlation with histological growth patterns. Oral Dis. 5:1999;117-122.
59. Yin H., Okada N., Takagi M. Comparison of apoptosis and apoptosis-related gene products between extranodal oral B-cell lymphoma and maxillofacial nodal B-cell lymphoma. J Oral Pathol Med. 30:2001;141-147.
60. Regezi J.A., McMillan A., Dekker N., et al. Apoptosis-associated proteins in oral lymphomas from HIV-positive patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 86:1998;196-202.
61. Nikitakis N.G., Lopes M.A., Pazoki A.E., Ord R.A., Sauk J.J. MDM2+/CDK4+/p53+ oral liposarcoma: case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 92:2001;194-201.
62. Lopes M.A., Nikitakis N.G., Ord R.A., Sauk J. Amplification and protein expression of chromosome 12q13-15 genes in osteosarcomas of the jaws. Oral Oncol. 37:2001;566-571.
63. Nikitakis N.G., Lopes M.A., Bailey J.S., Blanchaert R.H. Jr., Ord R.A., Sauk J.J. Oral leiomyosarcoma: review of the literature and report of 2 cases with assessment of the prognostic and diagnostic significance of immunohistochemical and molecular markers. Oral Oncol. 38:2002;201-208.
64. Kumamoto H., Kimi K., Ooya K. Immunohistochemical analysis of apoptosis-related factors (Fas, Fas ligand, caspase-3 and single-stranded DNA) in ameloblastomas. J Oral Pathol Med. 30:2001;596-602.
65. Sandra F., Nakamura N., Mitsuyasu T., Shiratsuchi Y., Ohishi M. Two relatively distinct patterns of ameloblastoma: an anti-apoptotic proliferating site in the outer layer (periphery) and a pro-apoptotic differentiating site in the inner layer (centre). Histopathology. 39:2001;93-98.
66. Kimi K., Kumamoto H., Ooya K., Motegi K. Immunohistochemical analysis of cell-cycle- and apoptosis-related factors in lining epithelium of odontogenic keratocysts. J Oral Pathol Med. 30:2001;434-442.
67. Lo Muzio L., Staibano S., Pannone G., et al. Expression of cell cycle and apoptosis-related proteins in sporadic odontogenic keratocysts and odontogenic keratocysts associated with the nevoid basal cell carcinoma syndrome. J Dent Res. 78:1999;1345-1353.
68. Tosios K.I., Kakarantza-Angelopoulou E., Kapranos N. Immunohistochemical study of bcl-2 protein, Ki-67 antigen and p53 protein in epithelium of glandular odontogenic cysts and dentigerous cysts. J Oral Pathol Med. 29:2000;139-144.
69. Abbas A.K. Die and let live: eliminating dangerous lymphocytes. Cell. 84:1996;655-657.
70. Rathmell J.C., Thompson C.B. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell. 109:2002;S97-S107.
71. Mountz J.D., Wu J., Cheng J., Zhou T. Autoimmune disease. A problem of defective apoptosis. Arthritis Rheum. 37:1994;1415-1420.
72. Rieux-Laucat F., Le Deist F., Hivroz C., et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science. 268:1995;1347-1349.
73. McHugh N.J. Systemic lupus erythematosus and dysregulated apoptosis - what is the evidence? Rheumatology. 41:2002;242-245.
74. Cheng J., Zhou T., Liu C., et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science. 263:1994;1759-1762.
75. Mountz J.D., Hsu H., Matsuki Y., Zhang H. Apoptosis and rheumatoid arthritis: past, present, and future directions. Curr Rheumatol Rep. 3:2001;70-78.
76. Pope R.M. Apoptosis as a therapeutic tool in rheumatoid arthritis. Nat Rev Immunol. 2:2002;527-535.
77. Beutler B. Autoimmunity and apoptosis: the Crohn's connection. Immunity. 15:2001;5-14.
78. Van Den Brande J.M., Peppelenbosch M.P., Van Deventer S.J. Treating Crohn's disease by inducing T lymphocyte apoptosis. Ann N Y Acad Sci. 973:2002;166-180.
79. Humphreys-Beher M.G., Peck A.B., Dang H., Talal N. The role of apoptosis in the initiation of the autoimmune response in Sjogren's syndrome. Clin Exp Immunol. 116:1999;383-387.
80. Tapinos N.I., Polihronis M., Tzioufas A.G., Moutsopoulos H.M. Sjögren's syndrome. Autoimmune epithelitis. Adv Exp Med Biol. 455:1999;127-134.
81. Abu-Helu R.F., Dimitriou I.D., Kapsogeorgou E.K., Moutsopoulos H.M., Manoussakis M.N. Induction of salivary gland epithelial cell injury in Sjögren's syndrome: in vitro assessment of t cell-derived cytokines and fas protein expression. J Autoimmun. 17:2001;141-153.
82. Kong L., Ogawa N., McGuff H.S., et al. Bcl-2 family expression in salivary glands from patients with primary Sjögren's syndrome: involvement of Bax in salivary gland destruction. Clin Immunol Immunopathol. 88:1998;133-141.
83. Mariette X., Sibilia J., Roux S., Meignin V., Janin A. A new defensive mechanism to prevent apoptosis in salivary ductal cells from patients with Sjögren's syndrome: over-expression of p53 and p21. Rheumatology. 41:2002;96-99.
84. Honma T., Saito T., Fujioka Y. Possible role of apoptotic cells of the oral epithelium in the pathogenesis of aphthous ulceration. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 59:1985;379-387.
85. Bloor B.K., Malik F.K., Odell E.W., Morgan P.R. Quantitative assessment of apoptosis in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 88:1999;187-195.
86. Neppelberg E., Johannessen A.C., Jonsson R. Apoptosis in oral lichen planus. Eur J Oral Sci. 109:2001;361-364.
87. Dekker N.P., Lozada-Nur F., Lagenaur L.A., MacPhail L.A., Bloom C.Y., Regezi J.A. Apoptosis-associated markers in oral lichen planus. J Oral Pathol Med. 26:1997;170-175.
88. Sklavounou A., Chrysomali E., Scorilas A., Karameris A. TNF-alpha expression and apoptosis-regulating proteins in oral lichen planus: a comparative immunohistochemical evaluation. J Oral Pathol Med. 29:2000;370-375.
89. Chrysomali E., Lozada-Nur F., Dekker N.P., Papanicolaou S.I., Regezi J.A. Apoptosis in oral erythema multiforme. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 83:1997;272-280.
90. Roulston A., Marcellus R.C., Branton P.E. Viruses and apoptosis. Annu Rev Microbiol. 53:1999;577-628.
91. Hay S., Kannourakis G. A time to kill: viral manipulation of the cell death program. J Gen Virol. 83:2002;1547-1564.
92. Benedict C.A., Norris P.S., Ware C.F. To kill or be killed: viral evasion of apoptosis. Nat Immunol. 3:2002;1013-1018.
93. Henderson S., Huen D., Rowe M., Dawson C., Johnson G., Rickinson A. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci U S A. 90:1993;8479-8483.
94. Chrysomali E., Greenspan J.S., Dekker N., Greenspan D., Regezi J.A. Apoptosis-associated proteins in oral hairy leukoplakia. Oral Dis. 2:1996;279-284.
95. Calzolari A., Papucci A., Baroni G., et al. Epstein-Barr virus infection and P53 expression in HIV-related oral large B cell lymphoma. Head Neck. 21:1999;454-460.
96. Porter S.R., Di Alberti L., Kumar N. Human herpes virus 8 (Kaposi's sarcoma herpesvirus). Oral Oncol. 34:1998;5-14.
97. Finzer P., Aguilar-Lemarroy A., Rosl F. The role of human papillomavirus oncoproteins E6 and E7 in apoptosis. Cancer Lett. 188:2002;15-24.
98. Itakura M., Mori S., Park N.H., Bonavida B. Both HPV and carcinogen contribute to the development of resistance to apoptosis during oral carcinogenesis. Int J Oncol. 16:2000;591-597.
99. Scully C., Laskaris G., Pindborg J., Porter S.R., Reichart P. Oral manifestations of HIV infection and their management I. More common lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 71:1991;158-166.
100. Scully C., Laskaris G., Pindborg J., Porter S.R., Reichart P. Oral manifestations of HIV infection and their management II. Less common lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 71:1991;167-171.
101. Gougeon M.L., Montagnier L. Apoptosis in AIDS. Science. 260:1993;1269-1270.
102. Badley A.D., Pilon A.A., Landay A., Lynch D.H. Mechanisms of HIV-associated lymphocyte apoptosis. Blood. 96:2000;2951-2964.
103. Roshal M., Zhu Y., Planelles V. Apoptosis in AIDS. Apoptosis. 6:2001;103-116.
104. Ross T.M. Using death to one's advantage: HIV modulation of apoptosis. Leukemia. 15:2001;332-341.
105. Greenberg P.L. Apoptosis and its role in the myelodysplastic syndromes: implications for disease natural history and treatment. Leuk Res. 22:1998;1123-1136.
106. Parker J.E., Mufti G.J. The role of apoptosis in the pathogenesis of the myelodysplastic syndromes. Int J Hematol. 73:2001;416-428.
107. Ismail M., Gibson F.M., Gordon-Smith E.C., Rutherford T.R. Bcl-2 and Bcl-x expression in the CD34+ cells of aplastic anaemia patients: relationship with increased apoptosis and upregulation of Fas antigen. Br J Haematol. 113:2001;706-712.
108. Aprikyan A.A., Liles W.C., Rodger E., Jonas M., Chi E.Y., Dale D.C. Impaired survival of bone marrow hematopoietic progenitor cells in cyclic neutropenia. Blood. 97:2001;147-153.
109. Kitada S., Pedersen I.M., Schimmer A.D., Reed J.C. Dysregulation of apoptosis genes in hematopoietic malignancies. Oncogene. 21:2002;3459-3474.
110. Offen D., Elkon H., Melamed E. Apoptosis as a general cell death pathway in neurodegenerative diseases. J Neural Transm Suppl. 58:2000;153-166.
111. Rodriguez M., Lucchesi B.R., Schaper J. Apoptosis in myocardial infarction. Ann Med. 34:2002;470-479.
112. Graham S.H., Chen J. Programmed cell death in cerebral ischemia. J Cereb Blood Flow Metab. 21:2001;99-109.
113. Baehrecke E.H. How death shapes life during development. Nat Rev Mol Cell Biol. 3:2002;779-787.
114. Brill A., Torchinsky A., Carp H., Toder V. The role of apoptosis in normal and abnormal embryonic development. J Assist Reprod Genet. 16:1999;512-519.
115. Shuler C.F. Programmed cell death and cell transformation in craniofacial development. Crit Rev Oral Biol Med. 6:1995;202-217.
116. Gastman B.R., Futrell J.W., Manders A.E. Apoptosis and plastic surgery. Plast Reconstr Surg. 111:2003;1481-1496.
117. Cuervo R., Valencia C., Chandraratna R.A., Covarrubias L. Programmed cell death is required for palate shelf fusion and is regulated by retinoic acid. Dev Biol. 245:2002;145-156.
118. Cohen M.M. Jr. Malformations of the craniofacial region: Evolutionary, embryonic, genetic, and clinical perspectives. Am J Med Genet. 115:2002;245-268.
119. Dry G.M., Yasinskaya Y.I., Williams J.K., et al. Inhibition of apoptosis: a potential mechanism for syndromic craniosynostosis. Plast Reconstr Surg. 107:2001;425-432.
120. Lemonnier J., Hay E., Delannoy P., et al. Increased osteoblast apoptosis in apert craniosynostosis: role of protein kinase C and interleukin-1. Am J Pathol. 158:2001;1833-1842.
121. Dixon J., Brakebusch C., Fassler R., Dixon M.J. Increased levels of apoptosis in the prefusion neural folds underlie the craniofacial disorder, Treacher Collins syndrome. Hum Mol Genet. 9:2000;1473-1480.
122. Cohen M.M. Jr. Nevoid basal cell carcinoma syndrome: molecular biology and new hypotheses. Int J Oral Maxillofac Surg. 28:1999;216-223.
123. Ingram W.J., Wicking C.A., Grimmond S.M., Forrest A.R., Wainwright B.J. Novel genes regulated by Sonic Hedgehog in pluripotent mesenchymal cells. Oncogene. 21:2002;8196-8205.
124. Wetmore C. Sonic Hedgehog in normal and neoplastic proliferation: insight gained from human tumors and animal models. Curr Opin Genet Dev. 13:2003;34-42.
125. Nishikawa S., Sasaki F. DNA localization in nuclear fragments of apoptotic ameloblasts using anti-DNA immunoelectron microscopy: programmed cell death of ameloblasts. Histochem Cell Biol. 104:1995;151-159.
126. Franquin J.C., Remusat M., Abou Hashieh I., Dejou J. Immunocytochemical detection of apoptosis in human odontoblasts. Eur J Oral Sci. 106:1998;384-387.
127. Vermelin L., Lecolle S., Septier D., Lasfargues J.J., Goldberg M. Apoptosis in human and rat dental pulp. Eur J Oral Sci. 104:1996;547-553.
128. Hatakeyama S., Tomichi N., Ohara-Nemoto Y., Satoh M. The immunohistochemical localization of Fas and Fas ligand in jaw bone and tooth germ of human fetuses. Calcif Tissue Int. 66:2000;330-337.
129. Cobourne M.T., Hardcastle Z., Sharpe P.T. Sonic Hedgehog regulates epithelial proliferation and cell survival in the developing tooth germ. J Dent Res. 80:2001;1974-1979.
130. Dassule H.R., Lewis P., Bei M., Maas R., McMahon A.P. Sonic Hedgehog regulates growth and morphogenesis of the tooth. Development. 127:2000;4775-4785.
131. Los M., Burek C.J., Stroh C., Benedyk K., Hug H., Mackiewicz A. Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design. Drug Discov Today. 8:2003;67-77.
132. Hersey P., Zhang X.D. Overcoming resistance of cancer cells to apoptosis. J Cell Physiol. 196:2003;9-18.
133. Watanabe M., Hitomi M., van der Wee K., et al. The pros and cons of apoptosis assays for use in the study of cells, tissues, and organs. Microsc Microanal. 8:2002;375-391.
134. Iwasa M., Imamura Y., Noriki S., Nishi Y., Kato H., Fukuda M. Immunohistochemical detection of early-stage carcinogenesis of oral leukoplakia by increased DNA-instability and various malignancy markers. Eur J Histochem. 45:2001;333-346.
135. Nagler R.M., Kerner H., Laufer D., Ben-Eliezer S., Minkov I., Ben-Itzhak O. Squamous cell carcinoma of the tongue: the prevalence and prognostic roles of p53, Bcl-2, c-erbB-2 and apoptotic rate as related to clinical and pathological characteristics in a retrospective study. Cancer Lett. 186:2002;137-150.
136. Nogami T., Kuyama K., Yamamoto H. Histopathological and immunohistochemical study of malignant transformation of oral leukoplakia, with special reference to apoptosis-related gene products and proliferative activity. Acta Otolaryngol. 123:2003;767-775.
137. Shintani S., Mihara M., Nakahara Y., et al. Apoptosis and p53 are associated with effect of preoperative radiation in oral squamous cell carcinomas. Cancer Lett. 154:2000;71-77.
138. Kapranos N., Stathopoulos G.P., Manolopoulos L., et al. p53, p21 and p27 protein expression in head and neck cancer and their prognostic value. Anticancer Res. 21:2001;521-528.
139. Fisher D.E. Apoptosis in cancer therapy: crossing the threshold. Cell. 78:1994;539-542.
140. Zhou L., Yuan R., Serggio L. Molecular mechanisms of irradiation-induced apoptosis. Front Biosci. 8:2003;D9-D19.
141. Debatin K.M., Poncet D., Kroemer G. Chemotherapy: targeting the mitochondrial cell death pathway. Oncogene. 21:2002;8786-8803.
142. Iwase M., Watanabe H., Kondo G., Ohashi M., Nagumo M. Enhanced susceptibility of oral squamous cell carcinoma cell lines to FAS-mediated apoptosis by cisplatin and 5-fluorouracil. Int J Cancer. 106:2003;619-625.
143. Tai K.W., Lii C.K., Chou M.Y., Chang Y.C. Relationship between intracellular glutathione level and the mode of cell death induced by pingyangmycin. Oral Oncol. 39:2003;13-18.
144. Nicolatou-Galitis O., Dardoufas K., Markoulatos P., et al. Oral pseudomembranous candidiasis, herpes simplex virus-1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte-macrophage colony-stimulating factor (GM-CSF) mouthwash. J Oral Pathol Med. 30:2001;471-480.
145. Sonis S.T. The biologic role for nuclear factor-kappaB in disease and its potential involvement in mucosal injury associated with anti-neoplastic therapy. Crit Rev Oral Biol Med. 13:2002;380-389.
146. Clayman G.L., Liu T.J., Overholt S.M., et al. Gene therapy for head and neck cancer. Comparing the tumor suppressor gene p53 and a cell cycle regulator WAF1/CIP1 (p21). Arch Otolaryngol Head Neck Surg. 122:1996;489-493.
147. Gibson S.A., Pellenz C., Hutchison R.E., Davey F.R., Shillitoe E.J. Induction of apoptosis in oral cancer cells by an anti-bcl-2 ribozyme delivered by an adenovirus vector. Clin Cancer Res. 6:2000;213-222.
148. Kushner D.M., Silverman R.H. Antisense cancer therapy: the state of the science. Curr Oncol Rep. 2:2000;23-30.
149. O-charoenrat P., Rhys-Evans P.H., Modjtahedi H., Eccles S.A. The role of c-erbB receptors and ligands in head and neck squamous cell carcinoma. Oral Oncol. 38:2002;627-640.
150. Song J.I., Grandis J.R. STAT signaling in head and neck cancer. Oncogene. 19:2000;2489-2495.
151. Ford A.C., Grandis J.R. Targeting epidermal growth factor receptor in head and neck cancer. Head Neck. 25:2003;67-73.
152. Nikitakis N.G., Hamburger A.W., Sauk J.J. The nonsteroidal anti-inflammatory drug sulindac causes downregulation of the signal transducer and activator of transcription 3 in human oral squamous cell carcinoma cells. Cancer Res. 62:2002;1004-1007.
153. Nikitakis N.G., Siavash H., Hebert C., Reynolds M.A., Hamburger A.W., Sauk J.J. 15-PGJ2, but not thiazolidinediones, inhibits cell growth, induces apoptosis, and causes downregulation of Stat3 in human oral SCCa cells. Br J Cancer. 87:2002;1396-1403.
154. Tsuruo T., Naito M., Tomida A., et al. Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal. Cancer Sci. 94:2003;15-21.
155. Petak I., Houghton J.A. Shared pathways: death receptors and cytotoxic drugs in cancer therapy. Pathol Oncol Res. 7:2001;95-106.